Tags

Type your tag names separated by a space and hit enter

Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia.
Saudi Med J. 2021 Jan; 42(1):38-43.SM

Abstract

OBJECTIVES

To assess the prevalence of anosmia in coronavirus-19 (COVID-19) patients. Coronavirus-19-related anosmia and hyposmia is a new emerging concept in the medical literature.

METHODS

A retrospective study on COVID-19 patients with anosmia and hyposmia was performed during the period between May-July, 2020. The inclusion criteria were all clinically stable COVID-19 patients less than 15 years old with positive reverse transcription-polymerase chain reaction (RT-PCR). Patients who refused to participate or leave incomplete questions were excluded. In this study, we investigated 1022 patients who met our criteria.

RESULTS

Olfactory dysfunction (OD) was reported by 53% of our COVID-19 patients, of which 32.7% were anosmic and 20.3% were hyposmic. Other neurological symptoms included ageusia (51.4%), fatigue (63%), myalgia (59.2%), and headache (50.9%), all of which showed significant association with OD. In addition, anosmia had a significant association with young age and female gender. However, there was no association between OD and pre-existing neurological disease.

CONCLUSION

Half of our COVID-19 patients presented OD (anosmia/hyposmia), which often associated with ageusia and many neurological symptoms.

Authors+Show Affiliations

Department of Medicine, Taif University, Taif, Kingdom of Saudi Arabia. E-mail. a.mubaraki@tu.edu.sa.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33399169

Citation

Mubaraki, Adnan A., et al. "Prevalence of Anosmia Among COVID-19 Patients in Taif City, Kingdom of Saudi Arabia." Saudi Medical Journal, vol. 42, no. 1, 2021, pp. 38-43.
Mubaraki AA, Alrbaiai GT, Sibyani AK, et al. Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia. Saudi Med J. 2021;42(1):38-43.
Mubaraki, A. A., Alrbaiai, G. T., Sibyani, A. K., Alhulayfi, R. M., Alzaidi, R. S., & Almalki, H. S. (2021). Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia. Saudi Medical Journal, 42(1), 38-43. https://doi.org/10.15537/smj.2021.1.25588
Mubaraki AA, et al. Prevalence of Anosmia Among COVID-19 Patients in Taif City, Kingdom of Saudi Arabia. Saudi Med J. 2021;42(1):38-43. PubMed PMID: 33399169.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia. AU - Mubaraki,Adnan A, AU - Alrbaiai,Ghaida T, AU - Sibyani,Afnan K, AU - Alhulayfi,Rahaf M, AU - Alzaidi,Reema S, AU - Almalki,Haneen S, PY - 2021/1/5/entrez PY - 2021/1/6/pubmed PY - 2021/1/20/medline SP - 38 EP - 43 JF - Saudi medical journal JO - Saudi Med J VL - 42 IS - 1 N2 - OBJECTIVES: To assess the prevalence of anosmia in coronavirus-19 (COVID-19) patients. Coronavirus-19-related anosmia and hyposmia is a new emerging concept in the medical literature. METHODS: A retrospective study on COVID-19 patients with anosmia and hyposmia was performed during the period between May-July, 2020. The inclusion criteria were all clinically stable COVID-19 patients less than 15 years old with positive reverse transcription-polymerase chain reaction (RT-PCR). Patients who refused to participate or leave incomplete questions were excluded. In this study, we investigated 1022 patients who met our criteria. RESULTS: Olfactory dysfunction (OD) was reported by 53% of our COVID-19 patients, of which 32.7% were anosmic and 20.3% were hyposmic. Other neurological symptoms included ageusia (51.4%), fatigue (63%), myalgia (59.2%), and headache (50.9%), all of which showed significant association with OD. In addition, anosmia had a significant association with young age and female gender. However, there was no association between OD and pre-existing neurological disease. CONCLUSION: Half of our COVID-19 patients presented OD (anosmia/hyposmia), which often associated with ageusia and many neurological symptoms. SN - 0379-5284 UR - https://www.unboundmedicine.com/medline/citation/33399169/Prevalence_of_anosmia_among_COVID_19_patients_in_Taif_City_Kingdom_of_Saudi_Arabia_ L2 - https://doi.org/10.15537/smj.2021.1.25588 DB - PRIME DP - Unbound Medicine ER -